JP2020514411A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514411A5 JP2020514411A5 JP2019562217A JP2019562217A JP2020514411A5 JP 2020514411 A5 JP2020514411 A5 JP 2020514411A5 JP 2019562217 A JP2019562217 A JP 2019562217A JP 2019562217 A JP2019562217 A JP 2019562217A JP 2020514411 A5 JP2020514411 A5 JP 2020514411A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- disease
- cancer
- zafirlukast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199341A JP2023030014A (ja) | 2017-01-30 | 2022-12-14 | チオールイソメラーゼ阻害剤およびその使用 |
| JP2024134797A JP2024161023A (ja) | 2017-01-30 | 2024-08-13 | チオールイソメラーゼ阻害剤およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762451858P | 2017-01-30 | 2017-01-30 | |
| US62/451,858 | 2017-01-30 | ||
| PCT/US2018/015694 WO2018140858A1 (en) | 2017-01-30 | 2018-01-29 | Thiol isomerases inhibitors and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199341A Division JP2023030014A (ja) | 2017-01-30 | 2022-12-14 | チオールイソメラーゼ阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020514411A JP2020514411A (ja) | 2020-05-21 |
| JP2020514411A5 true JP2020514411A5 (https=) | 2021-03-11 |
| JP7272655B2 JP7272655B2 (ja) | 2023-05-12 |
Family
ID=62978426
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562217A Active JP7272655B2 (ja) | 2017-01-30 | 2018-01-29 | チオールイソメラーゼ阻害剤およびその使用 |
| JP2022199341A Pending JP2023030014A (ja) | 2017-01-30 | 2022-12-14 | チオールイソメラーゼ阻害剤およびその使用 |
| JP2024134797A Pending JP2024161023A (ja) | 2017-01-30 | 2024-08-13 | チオールイソメラーゼ阻害剤およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199341A Pending JP2023030014A (ja) | 2017-01-30 | 2022-12-14 | チオールイソメラーゼ阻害剤およびその使用 |
| JP2024134797A Pending JP2024161023A (ja) | 2017-01-30 | 2024-08-13 | チオールイソメラーゼ阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11872210B2 (https=) |
| EP (1) | EP3585809B1 (https=) |
| JP (3) | JP7272655B2 (https=) |
| BR (1) | BR112019015721A2 (https=) |
| CA (2) | CA3052071A1 (https=) |
| WO (1) | WO2018140858A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019164874A1 (en) | 2018-02-20 | 2019-08-29 | Western New England University | Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases |
| CN113289020B (zh) * | 2021-05-17 | 2023-04-18 | 福州大学 | 蛋白质二硫键异构酶小分子抑制剂及其应用 |
| CA3219671A1 (en) | 2021-05-19 | 2022-11-24 | Thomas Christian Lines | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis |
| EP4518852A1 (en) * | 2022-05-06 | 2025-03-12 | Quercis Pharma AG | Method for treating cancers and neurological diseases using quercetin-containing compositions |
| WO2024039822A1 (en) * | 2022-08-19 | 2024-02-22 | Western New England University | Thiol isomerases inhibitors; preparation thereof; and methods of use thereof |
| WO2025094946A1 (ja) * | 2023-10-30 | 2025-05-08 | 国立大学法人東海国立大学機構 | 抗体又はその抗原結合性断片、がんの治療用キット、及びがんの治療用組成物 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA825413B (en) | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| GB8607294D0 (en) | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| US4985465A (en) | 1989-07-14 | 1991-01-15 | Hendler Sheldon S | Method for inhibiting viral and retroviral infections |
| US5565473A (en) | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| IL100091A (en) | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation |
| GB9027018D0 (en) | 1990-12-12 | 1991-01-30 | Ici Plc | Heterocyclic compounds |
| GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
| GB9726735D0 (en) | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Pharmaceutical compositions |
| IL139243A0 (en) * | 2000-10-24 | 2001-11-25 | Internat Specialty Products Is | Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof |
| DK1817301T3 (da) * | 2004-11-22 | 2012-02-27 | Lilly Co Eli | Forstærkere af glutamat-receptorer |
| KR100649009B1 (ko) | 2004-12-30 | 2006-11-27 | 동부일렉트로닉스 주식회사 | 시모스 이미지 센서의 광감지 소자 및 그의 제조방법 |
| WO2006127525A2 (en) | 2005-05-20 | 2006-11-30 | Jack Arbiser | Proteasome inhibitors and uses thereof |
| US8337814B2 (en) | 2005-12-15 | 2012-12-25 | Topical Sinus Therapeutics, Inc. | Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions |
| WO2008033466A2 (en) | 2006-09-14 | 2008-03-20 | Combinatorx (Singapore) Pre. Ltd. | Compositions and methods for treatment of viral diseases |
| US8058243B2 (en) | 2006-10-13 | 2011-11-15 | Hsc Research And Development Limited Partnership | Method for treating a brain cancer with ifenprodil |
| DE102007001804A1 (de) | 2007-01-12 | 2008-07-17 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Verwendung von GABAB-Rezeptor selektiven Agonisten zur Behandlung entzündlicher Hauterkrankungen |
| EP2269076A4 (en) | 2008-03-14 | 2011-04-06 | Nat Jewish Health | METHOD FOR DETERMINING THE RECOMMENDATION FOR TREATMENT WITH LEUKOTRIA MODIFIERS |
| US8980917B2 (en) | 2008-06-12 | 2015-03-17 | The Johns Hopkins University | Methods for treating or preventing brain infections |
| WO2013055674A1 (en) | 2011-10-10 | 2013-04-18 | The University Of Toledo | Method for treating infections |
| SG11201406142XA (en) | 2012-03-27 | 2014-10-30 | Univ Duke | Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage |
| CN103505731A (zh) | 2012-06-15 | 2014-01-15 | 中国药科大学 | 1型半胱氨酰白三烯受体拮抗剂在制备用于治疗阿尔茨海默病的药物中的用途 |
| CA2901413A1 (en) | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of vasculitis |
| US9616056B2 (en) | 2013-03-15 | 2017-04-11 | Institute For Cancer Research | Inhibition of leukotriene synthesis and activity in the treatment of sonic hedgehog-associated medulloblastoma |
| RU2667644C2 (ru) * | 2013-04-22 | 2018-09-21 | Тотиги Инститьют Оф Клиникал Патолоджи | Противоопухолевое средство |
| US20160145209A1 (en) * | 2013-06-21 | 2016-05-26 | The Broad Institute, Inc. | Compounds and compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase |
| GB201321089D0 (en) | 2013-11-29 | 2014-01-15 | Univ East London | Leukotriene receptor antagonists and their derivatives for use as antibacterial agents |
| WO2016118639A1 (en) * | 2015-01-20 | 2016-07-28 | The Trustees Of Columbia University In The City Of New York | Small molecule oxidizers of pdi and their use |
| JP6528314B2 (ja) * | 2015-03-20 | 2019-06-12 | 国立大学法人山口大学 | Ａ（Ｈ１Ｎ１）ｐｄｍ０９インフルエンザウイルス感染による気管支喘息の予防又は改善剤 |
-
2018
- 2018-01-29 BR BR112019015721-2A patent/BR112019015721A2/pt unknown
- 2018-01-29 CA CA3052071A patent/CA3052071A1/en active Pending
- 2018-01-29 WO PCT/US2018/015694 patent/WO2018140858A1/en not_active Ceased
- 2018-01-29 JP JP2019562217A patent/JP7272655B2/ja active Active
- 2018-01-29 EP EP18745381.6A patent/EP3585809B1/en active Active
- 2018-01-29 CA CA3282526A patent/CA3282526A1/en active Pending
- 2018-01-29 US US16/480,844 patent/US11872210B2/en active Active
-
2022
- 2022-12-14 JP JP2022199341A patent/JP2023030014A/ja active Pending
-
2023
- 2023-12-13 US US18/537,947 patent/US20240108600A1/en active Pending
-
2024
- 2024-08-13 JP JP2024134797A patent/JP2024161023A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514411A5 (https=) | ||
| JP2014077003A5 (https=) | ||
| JP2014515373A5 (https=) | ||
| Patel et al. | Contemporary developments in the discovery of selective factor Xa inhibitors: A review | |
| JP2015057436A5 (https=) | ||
| JP2015512406A5 (https=) | ||
| HUE034869T2 (en) | Combination therapy with substituted oxazolidinones | |
| JP2009138003A5 (https=) | ||
| FI4119569T3 (fi) | Konjugoituja antisense-yhdisteitä käytettäviksi hoidossa | |
| TWI377945B (en) | Prevention and treatment of thromboembolic disorders | |
| JP2024161023A (ja) | チオールイソメラーゼ阻害剤およびその使用 | |
| JP2018521086A5 (https=) | ||
| RU2013108390A (ru) | Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека | |
| JP2012525358A5 (https=) | ||
| JP2021505669A5 (https=) | ||
| CN110366427A (zh) | 一种预防和治疗病理性肾组织损伤的方法 | |
| CN117180245B (zh) | 辅酶q10组合物及其制备工艺和在保护心脏中的应用 | |
| JP2022512158A5 (https=) | ||
| CN103467383B (zh) | 一种丹皮酚与奥扎格雷偶联物及其药物组合物、医药用途 | |
| Paraskevaidis et al. | Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia | |
| CN103450087A (zh) | 丹皮酚与奥扎格雷偶联物的制备方法 | |
| JP2020509035A5 (https=) | ||
| Thomas et al. | Initial studies in man with a novel thromboxane receptor blocking drug GR32191 | |
| JP2016510738A5 (https=) | ||
| WO2021185356A1 (zh) | 丁基苯酞及其衍生物的用途 |